trending Market Intelligence /marketintelligence/en/news-insights/trending/4rlrbKOiGradqS6tKFsZCQ2 content esgSubNav
In This List

Report: J&J, Bayer ordered to pay $27.8M in Xarelto lawsuit

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Report: J&J, Bayer ordered to pay $27.8M in Xarelto lawsuit

Johnson & Johnson and Bayer AG were ordered by a Philadelphia court to pay $27.8 million to an Indiana couple over their failure to warn of internal bleeding risks associated with the blood thinner Xarelto, Reuters reported Dec. 5.

The Philadelphia state court jury charged the two pharmaceutical companies, which jointly developed the blockbuster drug, $1.8 million in compensatory and $26 million in punitive damages, Reuters reported quoting the couple's lawyer.

The two companies won three previous cases in federal court.

Xarelto was approved by the U.S. Food and Drug Administration in 2011.